Skip to main content
. 2023 Sep 14;30:79. doi: 10.1186/s12929-023-00972-w

Fig. 2.

Fig. 2

Overview of the various virus safety measures in place in the blood transfusion and industrial plasma fractionation industry, and supervised by regulatory authorities, as potential models to be implemented for optimal virus safety margin of pooled human platelet lysates and platelet extracellular vesicles for clinical applications. p-EV platelet extracellular vesicles, HPL human platelet lysate, NAT nucleic acid testing, PC platelet concentrate